Explore the Applications of Metabolomics in Drug Discovery & Precision Medicine

Metabolomics is an emerging ‘omics’ science that involves the study and analysis of the biochemical processes. It utilizes an array of analytical techniques to determine metabolites such as spectroscopy, chromatography, and multivariate analysis. The close link of metabolomics to the phenotype along with the non-invasive nature makes it an ideal tool for the healthcare, pharmaceutical, and agricultural industries.

In addition, emerging techniques such as metabolite imaging, and enhanced analytical technologies are boosting the use of metabolomics in various biomedical and pharmaceutical applications. It is popular for its usage in applications like identification of gene function, newborn screening, biotic-abiotic stress reaction analysis, substantial equivalence testing, phenotyping of genetically modified plants and so on. Recent advances in metabolomics technologies are paving way to a growing number of mainstream biomedical applications. The most cutting-edge example of metabolomics enabling precision medicine is the application of metabolomics to phenotype tumors and to design custom cancer therapies.

According to a report published by Allied Market Research, the metabolomics market size is anticipated to reach $6.6 billion with a considerable CAGR from 2021 to 2030. North America is currently dominating the market with the highest market share, while, the Asia-Pacific region is estimated to grow with the fastest pace.

The fact that metabolomics can help in early detection of chronic diseases, it is hugely preferred by healthcare providers. With the help of metabolomics, doctors are able to plan for an effective disease treatment which further improves patient survival rate and aids in the complete elimination of the disease from patient’s biological system. Also, numerous factors such as technological advancements in analytical techniques, a significant rise in adoption of metabolomics in drug discovery & precision medicine, remarkable recognition abilities of metabolomics, emergence of diagnostics tests for diagnosis of chronic diseases, increase in in R&D expenditure, and others are boosting the growth of the global metabolomics market in more than one way.

Moreover, the outbreak of the COVID-19 pandemic led to have a positive impact on the growth of the global metabolomics market. It has been used for COVID-19 related research. It has helped to reveal major stage associated shifts in the metabolome and their derivatives. Here, it is worth mentioning that metabolomics will keep growing in the field of diagnosis, prognosis, and therapeutic development, which in turn, will drive the growth of the market even more in the near future.

Related Post